Biomedical data analysis company Seven Bridges appoints CEO

Seven Bridges, a biomedical data analysis company based in Cambridge, Mass., promoted Brandi Davis-Dusenbery, PhD, to serve as CEO. She succeeds Deniz Kural, PhD, the company’s co-founder who is assuming the role of executive chairman of the board of directors.

Advertisement

Dr. Davis-Dusenbery most recently served as senior vice president of science and product at Seven Bridges. She was also instrumental in creating the Cancer Genomics Cloud, a National Cancer Institute pilot that today supports the analytic needs of about 1,500 researchers. Previously, she was a fellow at Boston-based Harvard University’s department of stem cell and regenerative biology.

Additionally, Seven Bridges made the following appointments to its leadership team:

•    Michael Hultner, PhD, is the company’s new chief strategy officer
•    Mike Falvey has joined as CFO
•    Andrew Gruen, PhD, was promoted to chief communications officer
•    Milan Mitrovic has been promoted to chief product officer
•    Bruce Press was promoted to executive vice president, business development and strategy

More articles on health IT:
Cerner public policy director weighs in on AHCA
752% ransomware increase in 2016 — 3 cyberthreat trends to know
Epic unveils App Orchard for third-party developers

Normal
0

false
false
false

MicrosoftInternetExplorer4

Biomedical data analysis company Seven Bridges appoints CEO

 

Seven Bridges, a biomedical data analysis company based in Cambridge, Mass., promoted Brandi Davis-Dusenbery, PhD, to serve as CEO. She succeeds Deniz Kural, PhD, the company’s co-founder who is assuming the role of executive chairman of the board of directors.

http://www.businesswire.com/news/home/20170315005507/en/

 

Dr. Davis-Dusenbery most recently served as senior vice president of science and product at Seven Bridges. She was also instrumental in creating the Cancer Genomics Cloud, a National Cancer Institute pilot that today supports the analytic needs of about 1,500 researchers. Previously, she was a fellow at Boston-based Harvard University’s department of stem cell and regenerative biology.

 

Additionally, Seven Bridges made the following appointments to its leadership team:

 

  • Michael Hultner, PhD, is the company’s new chief strategy officer
  • Mike Falvey has joined as CFO
  • Andrew Gruen, PhD, was promoted to chief communications officer
  • Milan Mitrovic has been promoted to chief product officer
  • Bruce Press was promoted to executive vice president, business development and strategy

 

More articles on health IT:

 

st1:*{behavior:url(#ieooui) }

/* Style Definitions */
table.MsoNormalTable
{mso-style-name:”Table Normal”;
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-style-noshow:yes;
mso-style-parent:””;
mso-padding-alt:0in 5.4pt 0in 5.4pt;
mso-para-margin:0in;
mso-para-margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:10.0pt;
font-family:”Times New Roman”;
mso-ansi-language:#0400;
mso-fareast-language:#0400;
mso-bidi-language:#0400;}

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.